CFGI Sentiment Reports · 15 quarters on record since 4 Jan 2023 · updated daily, as of 8 Sep 2026
Regeneron Pharmaceuticals Quarterly Sentiment Reports
Every quarter of Regeneron Pharmaceuticals (REGN) sentiment since 4 Jan 2023, newest first. Each quarter lists its price performance, high, low and average, its sentiment high, low and average, its most volatile day for each, the chart of the whole quarter, the 10 sub-algorithm averages and a short summary. Q3 2026 is the running quarter: an average of 62 (Greed).
Regeneron Pharmaceuticals sentiment at a glance
- Quarters on record
- 15, since 4 Jan 2023
- Average sentiment, all closed quarters
- 49 of 100 (Neutral)
- Greediest quarter
- Q1 2024, average 60 (Greed)
- Most fearful quarter
- Q4 2024, average 25 (Fear)
- Best quarter for the REGN price
- Q4 2025, +28.7%
- Worst quarter for the REGN price
- Q4 2024, -32.0%
- Running quarter
- Q3 2026, average 62 (Greed), REGN price +29.7%
Updated daily; last reading . Every number is computed from CFGI's stored daily readings.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2026 | -0.5%47 | -19.8%38 | +29.7%62 | - |
| 2025 | -11.3%42 | -14.9%44 | +5.1%53 | +28.7%59 |
| 2024 | +6.4%60 | +8.4%54 | -0.5%55 | -32.0%25 |
| 2023 | +13.1%57 | -13.0%44 | +14.6%56 | +7.4%51 |
Regeneron Pharmaceuticals Q3 2026 Sentiment Report
to In progress, updates daily| Performance | +29.7% | 1 Jul 2026 to 8 Sep 2026 |
|---|---|---|
| Price high | $852.03 | 2 Sep 2026 |
| Price low | $624.72 | 1 Jul 2026 |
| Average price | $747.92 | |
| Sentiment high | 83Extreme Greed | 31 Jul 2026 |
| Sentiment low | 35Fear | 23 Jul 2026 |
| Average sentiment | 62Greed | |
| Most volatile day (price) | +6.2% | 30 Jul 2026 |
| Most volatile day (sentiment) | -23 points (66 to 43) | 10 Jul 2026 |
47 scored trading days of 50. Price is the REGN price; performance is the first to the last scored day.
Q3 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2026, in its own band colour.
- Price67
- Volatility63
- Volume61
- Momentum63
- Technical58
- Social48
- Dominance64
- Trends34
- Whales49
- Orders47
Q3 2026 in brief
Regeneron Pharmaceuticals is averaging 62 of 100 (Greed) across 47 scored trading days in Q3 2026, opening at 42 on 1 Jul 2026 and reading 38 on 8 Sep 2026. Sentiment ran from 35 (Fear) on 23 Jul 2026 to 83 (Extreme Greed) on 31 Jul 2026. The REGN price moved +29.7% from $624.72 to $810.08, with its biggest single-day move of +6.2% on 30 Jul 2026. The quarter is still open and updates daily.
Regeneron Pharmaceuticals Q2 2026 Sentiment Report
to| Performance | -19.8% | 1 Apr 2026 to 30 Jun 2026 |
|---|---|---|
| Price high | $777.25 | 1 Apr 2026 |
| Price low | $600.66 | 1 Jun 2026 |
| Average price | $680.68 | |
| Sentiment high | 65Greed | 1 Apr 2026 |
| Sentiment low | 15Extreme Fear | 19 May 2026 |
| Average sentiment | 38Fear | |
| Most volatile day (price) | -9.8% | 18 May 2026 |
| Most volatile day (sentiment) | +21 points (24 to 45) | 4 May 2026 |
62 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q2 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2026, in its own band colour.
- Price41
- Volatility44
- Volume45
- Momentum45
- Technical41
- Socialn/a
- Dominance25
- Trendsn/a
- Whales29
- Orders33
Q2 2026 in brief
Regeneron Pharmaceuticals averaged 38 of 100 (Fear) across 62 scored trading days in Q2 2026, opening at 65 on 1 Apr 2026 and closing at 47 on 30 Jun 2026. Sentiment ran from 15 (Extreme Fear) on 19 May 2026 to 65 (Greed) on 1 Apr 2026. The REGN price moved -19.8% from $777.25 to $623.54, with its biggest single-day move of -9.8% on 18 May 2026.
Regeneron Pharmaceuticals Q1 2026 Sentiment Report
to| Performance | -0.5% | 2 Jan 2026 to 31 Mar 2026 |
|---|---|---|
| Price high | $812.27 | 7 Jan 2026 |
| Price low | $732.87 | 20 Mar 2026 |
| Average price | $765.59 | |
| Sentiment high | 71Greed | 8 Jan 2026 |
| Sentiment low | 29Fear | 14 Jan 2026 |
| Average sentiment | 47Neutral | |
| Most volatile day (price) | +4.6% | 7 Jan 2026 |
| Most volatile day (sentiment) | -31 points (68 to 37) | 12 Jan 2026 |
61 scored trading days of 64. Price is the REGN price; performance is the first to the last scored day.
Q1 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2026, in its own band colour.
- Price51
- Volatility48
- Volume49
- Momentum49
- Technical56
- Socialn/a
- Dominance30
- Trendsn/a
- Whales28
- Orders47
Q1 2026 in brief
Regeneron Pharmaceuticals averaged 47 of 100 (Neutral) across 61 scored trading days in Q1 2026, opening at 54 on 2 Jan 2026 and closing at 56 on 31 Mar 2026. Sentiment ran from 29 (Fear) on 14 Jan 2026 to 71 (Greed) on 8 Jan 2026. The REGN price moved -0.5% from $776.31 to $772.64, with its biggest single-day move of +4.6% on 7 Jan 2026.
Regeneron Pharmaceuticals Q4 2025 Sentiment Report
to| Performance | +28.7% | 1 Oct 2025 to 31 Dec 2025 |
|---|---|---|
| Price high | $787.32 | 25 Nov 2025 |
| Price low | $557.73 | 13 Oct 2025 |
| Average price | $679.11 | |
| Sentiment high | 82Extreme Greed | 25 Nov 2025 |
| Sentiment low | 32Fear | 3 Dec 2025 |
| Average sentiment | 59Neutral | |
| Most volatile day (price) | +11.8% | 28 Oct 2025 |
| Most volatile day (sentiment) | -25 points (75 to 50) | 1 Dec 2025 |
64 scored trading days of 66. Price is the REGN price; performance is the first to the last scored day.
Q4 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2025, in its own band colour.
- Price62
- Volatility58
- Volume61
- Momentum61
- Technical60
- Socialn/a
- Dominance23
- Trendsn/a
- Whales48
- Orders69
Q4 2025 in brief
Regeneron Pharmaceuticals averaged 59 of 100 (Neutral) across 64 scored trading days in Q4 2025, opening at 68 on 1 Oct 2025 and closing at 52 on 31 Dec 2025. Sentiment ran from 32 (Fear) on 3 Dec 2025 to 82 (Extreme Greed) on 25 Nov 2025. The REGN price moved +28.7% from $599.94 to $771.87, with its biggest single-day move of +11.8% on 28 Oct 2025.
Regeneron Pharmaceuticals Q3 2025 Sentiment Report
to| Performance | +5.1% | 1 Jul 2025 to 30 Sep 2025 |
|---|---|---|
| Price high | $598.71 | 18 Sep 2025 |
| Price low | $534.91 | 1 Jul 2025 |
| Average price | $565.42 | |
| Sentiment high | 68Greed | 21 Aug 2025 |
| Sentiment low | 31Fear | 25 Sep 2025 |
| Average sentiment | 53Neutral | |
| Most volatile day (price) | -4.7% | 23 Sep 2025 |
| Most volatile day (sentiment) | -24 points (63 to 39) | 23 Sep 2025 |
64 scored trading days of 66. Price is the REGN price; performance is the first to the last scored day.
Q3 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2025, in its own band colour.
- Price54
- Volatility51
- Volume51
- Momentum52
- Technical49
- Socialn/a
- Dominance16
- Trendsn/a
- Whales97
- Orders56
Q3 2025 in brief
Regeneron Pharmaceuticals averaged 53 of 100 (Neutral) across 64 scored trading days in Q3 2025, opening at 57 on 1 Jul 2025 and closing at 51 on 30 Sep 2025. Sentiment ran from 31 (Fear) on 25 Sep 2025 to 68 (Greed) on 21 Aug 2025. The REGN price moved +5.1% from $534.91 to $562.27, with its biggest single-day move of -4.7% on 23 Sep 2025.
Regeneron Pharmaceuticals Q2 2025 Sentiment Report
to| Performance | -14.9% | 1 Apr 2025 to 30 Jun 2025 |
|---|---|---|
| Price high | $625.60 | 2 Apr 2025 |
| Price low | $483.07 | 5 Jun 2025 |
| Average price | $558.13 | |
| Sentiment high | 67Greed | 20 May 2025 |
| Sentiment low | 18Extreme Fear | 8 Apr 2025 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -19.0% | 30 May 2025 |
| Most volatile day (sentiment) | -38 points (60 to 22) | 30 May 2025 |
62 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q2 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2025, in its own band colour.
- Price42
- Volatility47
- Volume48
- Momentum47
- Technical38
- Socialn/a
- Dominance12
- Trendsn/a
- Whales99
- Orders33
Q2 2025 in brief
Regeneron Pharmaceuticals averaged 44 of 100 (Neutral) across 62 scored trading days in Q2 2025, opening at 32 on 1 Apr 2025 and closing at 54 on 30 Jun 2025. Sentiment ran from 18 (Extreme Fear) on 8 Apr 2025 to 67 (Greed) on 20 May 2025. The REGN price moved -14.9% from $617.00 to $525.00, with its biggest single-day move of -19.0% on 30 May 2025.
Regeneron Pharmaceuticals Q1 2025 Sentiment Report
to| Performance | -11.3% | 2 Jan 2025 to 31 Mar 2025 |
|---|---|---|
| Price high | $744.83 | 10 Mar 2025 |
| Price low | $634.14 | 25 Mar 2025 |
| Average price | $687.82 | |
| Sentiment high | 76Greed | 10 Mar 2025 |
| Sentiment low | 23Fear | 14 Jan 2025 |
| Average sentiment | 42Neutral | |
| Most volatile day (price) | +5.3% | 10 Mar 2025 |
| Most volatile day (sentiment) | -28 points (69 to 41) | 12 Mar 2025 |
60 scored trading days of 64. Price is the REGN price; performance is the first to the last scored day.
Q1 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2025, in its own band colour.
- Price44
- Volatility42
- Volume39
- Momentum45
- Technical40
- Socialn/a
- Dominance10
- Trendsn/a
- Whales83
- Orders43
Q1 2025 in brief
Regeneron Pharmaceuticals averaged 42 of 100 (Neutral) across 60 scored trading days in Q1 2025, opening at 33 on 2 Jan 2025 and closing at 35 on 31 Mar 2025. Sentiment ran from 23 (Fear) on 14 Jan 2025 to 76 (Greed) on 10 Mar 2025. The REGN price moved -11.3% from $715.19 to $634.23, with its biggest single-day move of +5.3% on 10 Mar 2025.
Regeneron Pharmaceuticals Q4 2024 Sentiment Report
to| Performance | -32.0% | 1 Oct 2024 to 31 Dec 2024 |
|---|---|---|
| Price high | $1,047 | 1 Oct 2024 |
| Price low | $701.85 | 20 Dec 2024 |
| Average price | $839.22 | |
| Sentiment high | 59Neutral | 9 Dec 2024 |
| Sentiment low | 7Extreme Fear | 4 Nov 2024 |
| Average sentiment | 25Fear | |
| Most volatile day (price) | -9.2% | 31 Oct 2024 |
| Most volatile day (sentiment) | -24 points (45 to 21) | 12 Dec 2024 |
64 scored trading days of 66. Price is the REGN price; performance is the first to the last scored day.
Q4 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2024, in its own band colour.
- Price26
- Volatility36
- Volume36
- Momentum34
- Technical41
- Socialn/a
- Dominance10
- Trendsn/a
- Whalesn/a
- Orders12
Q4 2024 in brief
Regeneron Pharmaceuticals averaged 25 of 100 (Fear) across 64 scored trading days in Q4 2024, opening at 43 on 1 Oct 2024 and closing at 32 on 31 Dec 2024. Sentiment ran from 7 (Extreme Fear) on 4 Nov 2024 to 59 (Neutral) on 9 Dec 2024. The REGN price moved -32.0% from $1,047 to $712.33, with its biggest single-day move of -9.2% on 31 Oct 2024.
Regeneron Pharmaceuticals Q3 2024 Sentiment Report
to| Performance | -0.5% | 1 Jul 2024 to 30 Sep 2024 |
|---|---|---|
| Price high | $1,202 | 27 Aug 2024 |
| Price low | $1,024 | 3 Jul 2024 |
| Average price | $1,113 | |
| Sentiment high | 84Extreme Greed | 15 Aug 2024 |
| Sentiment low | 14Extreme Fear | 25 Sep 2024 |
| Average sentiment | 55Neutral | |
| Most volatile day (price) | -4.6% | 23 Sep 2024 |
| Most volatile day (sentiment) | +31 points (43 to 74) | 8 Aug 2024 |
64 scored trading days of 66. Price is the REGN price; performance is the first to the last scored day.
Q3 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2024, in its own band colour.
- Price57
- Volatility51
- Volume48
- Momentum50
- Technical58
- Socialn/a
- Dominance69
- Trendsn/a
- Whalesn/a
- Orders42
Q3 2024 in brief
Regeneron Pharmaceuticals averaged 55 of 100 (Neutral) across 64 scored trading days in Q3 2024, opening at 54 on 1 Jul 2024 and closing at 45 on 30 Sep 2024. Sentiment ran from 14 (Extreme Fear) on 25 Sep 2024 to 84 (Extreme Greed) on 15 Aug 2024. The REGN price moved -0.5% from $1,057 to $1,051, with its biggest single-day move of -4.6% on 23 Sep 2024.
Regeneron Pharmaceuticals Q2 2024 Sentiment Report
to| Performance | +8.4% | 1 Apr 2024 to 28 Jun 2024 |
|---|---|---|
| Price high | $1,071 | 25 Jun 2024 |
| Price low | $883.20 | 26 Apr 2024 |
| Average price | $969.40 | |
| Sentiment high | 80Extreme Greed | 25 Jun 2024 |
| Sentiment low | 19Extreme Fear | 15 Apr 2024 |
| Average sentiment | 54Neutral | |
| Most volatile day (price) | +3.8% | 2 May 2024 |
| Most volatile day (sentiment) | +22 points (50 to 72) | 2 May 2024 |
63 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q2 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2024, in its own band colour.
- Price55
- Volatility56
- Volume54
- Momentum56
- Technical58
- Socialn/a
- Dominance45
- Trendsn/a
- Whalesn/a
- Orders50
Q2 2024 in brief
Regeneron Pharmaceuticals averaged 54 of 100 (Neutral) across 63 scored trading days in Q2 2024, opening at 56 on 1 Apr 2024 and closing at 52 on 28 Jun 2024. Sentiment ran from 19 (Extreme Fear) on 15 Apr 2024 to 80 (Extreme Greed) on 25 Jun 2024. The REGN price moved +8.4% from $969.31 to $1,051, with its biggest single-day move of +3.8% on 2 May 2024.
Regeneron Pharmaceuticals Q1 2024 Sentiment Report
to| Performance | +6.4% | 2 Jan 2024 to 28 Mar 2024 |
|---|---|---|
| Price high | $993.35 | 27 Feb 2024 |
| Price low | $902.69 | 9 Jan 2024 |
| Average price | $950.88 | |
| Sentiment high | 81Extreme Greed | 3 Jan 2024 |
| Sentiment low | 44Neutral | 6 Feb 2024 |
| Average sentiment | 60Greed | |
| Most volatile day (price) | -2.2% | 29 Feb 2024 |
| Most volatile day (sentiment) | -21 points (70 to 49) | 29 Feb 2024 |
61 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q1 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2024, in its own band colour.
- Price62
- Volatility54
- Volume53
- Momentum56
- Technical61
- Socialn/a
- Dominance58
- Trendsn/a
- Whalesn/a
- Orders59
Q1 2024 in brief
Regeneron Pharmaceuticals averaged 60 of 100 (Greed) across 61 scored trading days in Q1 2024, opening at 79 on 2 Jan 2024 and closing at 49 on 28 Mar 2024. Sentiment ran from 44 (Neutral) on 6 Feb 2024 to 81 (Extreme Greed) on 3 Jan 2024. The REGN price moved +6.4% from $905.00 to $962.49, with its biggest single-day move of -2.2% on 29 Feb 2024.
Regeneron Pharmaceuticals Q4 2023 Sentiment Report
to| Performance | +7.4% | 2 Oct 2023 to 29 Dec 2023 |
|---|---|---|
| Price high | $881.70 | 28 Dec 2023 |
| Price low | $775.18 | 27 Oct 2023 |
| Average price | $823.50 | |
| Sentiment high | 76Greed | 13 Dec 2023 |
| Sentiment low | 26Fear | 23 Oct 2023 |
| Average sentiment | 51Neutral | |
| Most volatile day (price) | +3.5% | 2 Nov 2023 |
| Most volatile day (sentiment) | -24 points (59 to 35) | 9 Nov 2023 |
63 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q4 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2023, in its own band colour.
- Price52
- Volatility53
- Volume52
- Momentum53
- Technical58
- Socialn/a
- Dominance46
- Trendsn/a
- Whalesn/a
- Orders30
Q4 2023 in brief
Regeneron Pharmaceuticals averaged 51 of 100 (Neutral) across 63 scored trading days in Q4 2023, opening at 42 on 2 Oct 2023 and closing at 75 on 29 Dec 2023. Sentiment ran from 26 (Fear) on 23 Oct 2023 to 76 (Greed) on 13 Dec 2023. The REGN price moved +7.4% from $818.03 to $878.29, with its biggest single-day move of +3.5% on 2 Nov 2023.
Regeneron Pharmaceuticals Q3 2023 Sentiment Report
to| Performance | +14.6% | 3 Jul 2023 to 29 Sep 2023 |
|---|---|---|
| Price high | $844.37 | 21 Aug 2023 |
| Price low | $692.45 | 7 Jul 2023 |
| Average price | $785.91 | |
| Sentiment high | 81Extreme Greed | 22 Aug 2023 |
| Sentiment low | 25Fear | 7 Jul 2023 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | +5.4% | 3 Aug 2023 |
| Most volatile day (sentiment) | +24 points (42 to 66) | 3 Aug 2023 |
63 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q3 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2023, in its own band colour.
- Price58
- Volatility59
- Volume59
- Momentum57
- Technical56
- Socialn/a
- Dominance36
- Trendsn/a
- Whalesn/a
- Orders50
Q3 2023 in brief
Regeneron Pharmaceuticals averaged 56 of 100 (Neutral) across 63 scored trading days in Q3 2023, opening at 44 on 3 Jul 2023 and closing at 47 on 29 Sep 2023. Sentiment ran from 25 (Fear) on 7 Jul 2023 to 81 (Extreme Greed) on 22 Aug 2023. The REGN price moved +14.6% from $718.09 to $822.96, with its biggest single-day move of +5.4% on 3 Aug 2023.
Regeneron Pharmaceuticals Q2 2023 Sentiment Report
to| Performance | -13.0% | 3 Apr 2023 to 30 Jun 2023 |
|---|---|---|
| Price high | $830.35 | 13 Apr 2023 |
| Price low | $700.03 | 28 Jun 2023 |
| Average price | $771.00 | |
| Sentiment high | 70Greed | 5 Apr 2023 |
| Sentiment low | 14Extreme Fear | 28 Jun 2023 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -8.7% | 27 Jun 2023 |
| Most volatile day (sentiment) | -41 points (61 to 20) | 27 Jun 2023 |
62 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q2 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2023, in its own band colour.
- Price48
- Volatility47
- Volume49
- Momentum46
- Technical48
- Socialn/a
- Dominance34
- Trendsn/a
- Whalesn/a
- Orders33
Q2 2023 in brief
Regeneron Pharmaceuticals averaged 44 of 100 (Neutral) across 62 scored trading days in Q2 2023, opening at 69 on 3 Apr 2023 and closing at 25 on 30 Jun 2023. Sentiment ran from 14 (Extreme Fear) on 28 Jun 2023 to 70 (Greed) on 5 Apr 2023. The REGN price moved -13.0% from $826.19 to $718.54, with its biggest single-day move of -8.7% on 27 Jun 2023.
Regeneron Pharmaceuticals Q1 2023 Sentiment Report
to| Performance | +13.1% | 4 Jan 2023 to 31 Mar 2023 |
|---|---|---|
| Price high | $826.97 | 28 Mar 2023 |
| Price low | $680.49 | 9 Jan 2023 |
| Average price | $754.76 | |
| Sentiment high | 84Extreme Greed | 4 Jan 2023 |
| Sentiment low | 24Fear | 10 Jan 2023 |
| Average sentiment | 57Neutral | |
| Most volatile day (price) | -7.7% | 9 Jan 2023 |
| Most volatile day (sentiment) | +37 points (26 to 63) | 12 Jan 2023 |
61 scored trading days of 65. Price is the REGN price; performance is the first to the last scored day.
Q1 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2023, in its own band colour.
- Price55
- Volatility59
- Volume59
- Momentum55
- Technical58
- Socialn/a
- Dominance60
- Trendsn/a
- Whalesn/a
- Orders41
Q1 2023 in brief
Regeneron Pharmaceuticals averaged 57 of 100 (Neutral) across 61 scored trading days in Q1 2023, opening at 84 on 4 Jan 2023 and closing at 62 on 31 Mar 2023. Sentiment ran from 24 (Fear) on 10 Jan 2023 to 84 (Extreme Greed) on 4 Jan 2023. The REGN price moved +13.1% from $726.49 to $821.67, with its biggest single-day move of -7.7% on 9 Jan 2023.
How these reports are built
Each quarter is computed from CFGI's stored daily readings of the Fear and Greed Index: the last 1d reading of every UTC day in the window, its 10 components and the stored daily REGN price. Averages are over scored trading days only. A running quarter updates with every data cycle; a closed quarter is final. Cite as: CFGI, Regeneron Pharmaceuticals Quarterly Sentiment Reports, cfgi.io, 8 Sep 2026, https://cfgi.io/regeneron-pharmaceuticals-stock-quarterly-report/.
Frequently asked questions
Where do these Regeneron Pharmaceuticals quarterly reports come from?
What is the most volatile day?
How does a quarter get a Partial record tag?
Where are the monthly reports?
CFGI is a sentiment gauge, not financial advice. It does not predict price or tell users when to trade. These reports describe what the crowd did; they are a mirror of the crowd, not a forecast.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.